De Luca A, Pellizzari Tregno F, Sau A, Pastore A, Palumbo C, Alama A, Cicconi R, Federici G, Caccuri AM (2013) Glutathione S-transferase P1-1 as a target for mesothelioma treatment
Baseline labs: IGF-1, fasting glucose, HbA1c, lipid panel, and comprehensive metabolic panel are standard before initiation
Separate ex vivo and in vitro studies suggest that combining GHK-Cu with hyaluronic acid, especially lower-molecular-weight fractions at specific ratios, may further support collagen IV presence at the dermalepidermal junction
It is not a replacement for these medications but rather a different approach targeting a distinct metabolic pathway
It challenged the pharmacy's marketing as if glutathione were an approved drug
Warnings for Cyanocobalamin Patients with early Leber's disease (hereditary optic nerve atrophy) who were treated with cyanocobalamin suffered severe and swift optic atrophy